Cancer Detection And Diagnosis Research federal funding in FY2024

The relationship: Cancer Detection And Diagnosis Research and fiscal year 2024

Two tables meet. One table is CFDA 93.394 (Cancer Detection And Diagnosis Research). The other is fiscal year 2024. $3,449,034,200.27 is the obligation sum on that intersection. The FY cell is 85.1% of the program-wide $4,051,456,547.91 book in this extract. It is not every FY2024 federal dollar and not an outlay. FEC donations do not fund these USAspending obligations.

CFDA 93.394 is the CFDA hub. FY2024 federal spending is the fiscal-year hub. All programs is the catalog directory. All spending ties lists other spending ties. Only this page applies both filters at once. A later ingest can restate $3,449,034,200.27 without changing the join keys.

Program facts that stay on CFDA 93.394

Official title: CANCER DETECTION AND DIAGNOSIS RESEARCH. Program-wide obligations in this extract: $4,051,456,547.91. Program-wide awards: 1,875. Those parent figures are not the FY2024 headline. This packet lists no contractors and no award recipients. Mixing the listing with Cancer Biology Research and other cancer catalog lines with different CFDA numbers would invent a combined book.

Cancer Detection And Diagnosis Research (CFDA 93.394) is not the same overlay as biology or prevention listings on other CFDA numbers. Mixing those listings into the FY2024 cell would invent a combined cancer total the packet never computed. The packet publishes no disease-site split and no named institutions.

FY2024 as a yearlyTrend bucket, not a finished cash year

Fiscal year 2024 can still be incomplete. Performance can spill across adjacent years. $3,449,034,200.27 remains an obligation aggregate for Cancer Detection And Diagnosis Research in FY2024. Outlays are a different field and are not published here. Do not quote $3,449,034,200.27 as cash already cleared.

Award counts: 1,441 on the year, 1,875 on the parent

The year cell lists 1,441 awards. That is not 1,441 completed studies or 1,441 unique laboratories. About $2,393,500.49 per year-cell record is arithmetic on $3,449,034,200.27 and 1,441, not a typical payment. The parent’s 1,875 awards belong on CFDA 93.394 without the year filter. Unique recipients remain unpublished.

How to cite Cancer Detection And Diagnosis Research in FY2024

Cite: Cancer Detection And Diagnosis Research (CFDA 93.394) obligated $3,449,034,200.27 in FY2024, per USAspending.gov yearlyTrend. Keep both keys. Keep the word obligations. The join is not a screening-volume census, a cancer-incidence atlas, or a trial-enrollment table and not a named-lab roster, a principal-investigator directory, or a tumor-site split.

Live paths: /programs/93.394/, /fiscal-years/2024/, /programs/, /ties/. Prefer CFDA 93.394 and FY2024 federal spending when live tables move. All programs and All spending ties are indexes, not this cell. Do not invent contractors. Keep Cancer Detection And Diagnosis Research and FY2024 on the same line as $3,449,034,200.27. CFDA 93.394 remains the program key; fiscal year 2024 remains the time key. Obligations of $3,449,034,200.27 are not outlays and not a named-lab roster, a principal-investigator directory, or a tumor-site split. Original filings remain on USAspending.gov for this yearlyTrend cell. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished on this program-year join. All programs and All spending ties are larger indexes than this cell. A later USAspending ingest can restate $3,449,034,200.27 without changing CFDA 93.394 or FY2024. Do not invent contractors or award recipients for Cancer Detection And Diagnosis Research. The 1,441 year-cell awards are still not 1,441 completed studies or 1,441 unique laboratories. Keep Cancer Detection And Diagnosis Research and FY2024 on the same line as $3,449,034,200.27. CFDA 93.394 remains the program key; fiscal year 2024 remains the time key. Obligations of $3,449,034,200.27 are not outlays and not a named-lab roster, a principal-investigator directory, or a tumor-site split. Original filings remain on USAspending.gov for this yearlyTrend cell.

Questions

How much Cancer Detection And Diagnosis Research spending is in FY2024?

USAspending.gov records $3,449,034,200.27 in Cancer Detection And Diagnosis Research obligations for FY2024 (CFDA 93.394). That is a program × year join, not an outlay and not the government-wide FY2024 total. Original filings remain on USAspending.gov.

Do 1,441 awards mean 1,441 detection studies finished in FY2024?

No. 1,441 is the year-cell award-record count, not 1,441 completed studies or 1,441 unique laboratories. A mean of about $2,393,500.49 is arithmetic on packet facts, not a typical payment. Unique recipients are unpublished. Original filings remain on USAspending.gov.

Is $3,449,034,200.27 cash already paid for Cancer Detection And Diagnosis Research in FY2024?

No. $3,449,034,200.27 is an obligation aggregate for Cancer Detection And Diagnosis Research in FY2024. Outlays, remaining balances, and cash already paid are unpublished on this packet. Keep the obligation label. USAspending.gov remains the source. Keep Cancer Detection And Diagnosis Research and FY2024 together when citing $3,449,034,200.27.

Which pages parent Cancer Detection And Diagnosis Research FY2024?

CFDA 93.394 is the program parent. FY2024 federal spending is the year parent. All programs lists other CFDA hubs. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes Cancer Detection And Diagnosis Research × FY2024 at $3,449,034,200.27.